Courtney S Davis

Learn More
OBJECTIVE To assess the impact of a multipreceptor approach to facilitating topic discussions on students' knowledge and confidence in clinical decision-making during an ambulatory care advanced pharmacy practice experiences (APPEs). DESIGN Faculty members with relevant expertise and experience facilitated discussions with fourth-year doctor of pharmacy(More)
PURPOSE The purpose of this article is to educate nurse practitioners about the newest class of oral medications developed to treat type 2 diabetes mellitus (T2DM). This article will review dapagliflozin and canagliflozin, the two Food and Drug Administration (FDA) approved sodium glucose co-transporter 2 (SGLT2) inhibitors, and discuss their place in(More)
OBJECTIVE The national initiative, Project IMProving America's Communities Together (IMPACT): Diabetes, was intended to scale a proven American Pharmacists Association (APhA) Foundation process model, which integrates pharmacists on the collaborative health-care team, in communities greatly affected by diabetes to improve key indicators of diabetes. This(More)
OBJECTIVES To decrease the amount of pharmaceuticals present in our community's water supply, reduce the accidental and intentional ingestion of pharmaceuticals, and increase awareness of proper medication disposal. SETTING Knoxville, TN, from November 2008 to November 2009. PRACTICE DESCRIPTION Medication and thermometer collection events were held at(More)
PURPOSE The purpose of this article is to educate nurse practitioners about Afrezza. DATA SOURCES A comprehensive literature search was conducted using MEDLINE for clinical trial data. Information from the Centers of Disease Control and Prevention, World Health Organization, clinical guidelines, Food and Drug Administration labeling, briefings, and press(More)
PURPOSE The purpose of this article is to educate nurse practitioners about the role of Toujeo®, insulin glargine U-300 (Gla-300), which is a new option for the treatment of diabetes mellitus. DATA SOURCES A comprehensive literature search was conducted using MEDLINE with the key terms: insulin glargine 300, Toujeo, Gla-300, and EDITION for clinical trial(More)
Canagliflozin-metformin is one of the newest combination therapies available for the treatment of type 2 diabetes mellitus (T2DM). Canagliflozin is an inhibitor of the sodium-glucose co-transporter 2 which causes an increase in the urinary excretion of glucose. In the present article, we review the safety and efficacy of canagliflozin and metformin from(More)
  • 1